We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European shares deepen losses after hawkish Fed comments

Fri, 18th Jun 2021 09:40

* Basic resources stocks worst weekly performers

* Bank stocks lead losses for the day

* STOXX 600 marks worst week since late-Feb, down 1.2%

* Bank of Ireland at bottom of STOXX 600
(Updates to market close)

By Sagarika Jaisinghani and Ambar Warrick

June 18 (Reuters) - A slide in European bank and energy
stocks was exacerbated by hawkish comments from a Federal
Reserve official, which also saw the STOXX 600 index snap a
four-week winning streak as fears of U.S. policy tightening came
to the fore.

The pan-European STOXX 600 index ended 1.6% lower
in its worst day in five weeks, with bank and energy
stocks leading declines. The index also dropped 1.2%
this week.

Sentiment was also dented by the European Union losing its
bid for speedier COVID-19 vaccination deliveries from UK
drugmaker AstraZeneca, which could slow the pace of a
steady vaccination campaign.

The banking sector, which typically does well when interest
rates are high, plunged nearly 3% as concerns over an eventual
reduction in liquidity saw investors locking in recent gains.

Fed official James Bullard said the Fed could start
tightening rates by as early as late 2022, calling it a natural
response to economic growth and inflation moving quicker than
expected, as the United States reopens from the COVID-19
pandemic.

His comments came after the Fed signalled a hawkish tilt
earlier this week, which had rattled risk-driven markets.

Commodity markets were also hit by the Fed, with European
energy stocks falling 2.9% on Friday, in line with lower
oil prices.

Basic resources stocks were the worst performers
this week, down nearly 8% as fears over Chinese caps on copper
prices weighed. The sector had its worst week since the peak of
the COVID-19 pandemic in March 2020.

"The market has been polarised in certain positions," said
Andrea Cicione, head of strategy at TS Lombard.

"We've been very positive on financials and energy since
last November and now we're seeing a reversal of that as
investors scale back. But this is temporary phase; there's
definitely more upside for financials and energy, which are
still relatively cheap."

Germany's DAX index fell 1.8% as data showed a
bigger-than-expected jump in May producer prices.

Bank of Ireland tumbled 7% to the bottom of the
STOXX 600, after it announced the sale of some non-performing
mortgage exposures.

Danish pharmaceutical company Orphazyme sank 44%
after saying it had failed to win support from the U.S. Food and
Drug Administration for its arimoclomol drug, a treatment
designed for genetic disorder Niemann-Pick disease type C.

Tesco, Britain's biggest retailer, fell 4.1% as it
reported a sharp slowdown in quarterly underlying UK sales
growth, while car dealership Inchcape rose 3% after
raising its annual profit forecast.
(Reporting by Sagarika Jaisinghani in Bengaluru; Editing by
Shounak Dasgupta, Rashmi Aich and Jonathan Oatis)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.